Officer sold ~$438K of Regeneron Pharmaceuticals
Scheduled in advanceLoading…
Reporting person on SEC Form 4
Jason Pitofsky
Jason Pitofsky is VP Controller at Regeneron Pharmaceuticals. OQRO lists 17 transactions filed with the SEC under this name, the latest on Feb 11, 2026, each linked to the official Form 4.
VP Controller
Disclosures on record
17
Companies involved
1
Disclosure history
Officer sold ~$405K of Regeneron Pharmaceuticals
Scheduled in advanceOfficer sold ~$304K of Regeneron Pharmaceuticals
Scheduled in advanceOfficer sold ~$160K of Regeneron Pharmaceuticals
Scheduled in advanceOfficer sold ~$113K of Regeneron Pharmaceuticals
Scheduled in advanceOfficer sold ~$59K of Regeneron Pharmaceuticals
Scheduled in advanceOfficer sold ~$42K of Regeneron Pharmaceuticals
Scheduled in advanceOfficer sold ~$29K of Regeneron Pharmaceuticals
Scheduled in advanceOfficer sold ~$20K of Regeneron Pharmaceuticals
Scheduled in advanceOfficer sold ~$16K of Regeneron Pharmaceuticals
Scheduled in advanceOfficer sold ~$785 of Regeneron Pharmaceuticals
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Officer sold
~$281KReported value · 431 sh @ $651.43
Stock since the trade +10.5% · S&P 500 +15.5% · to Oct 5
Regeneron Pharmaceuticals's VP Controller sold $281K of Regeneron Pharmaceuticals shares. Nobody planned it ahead of time.